The Food and Drug Administration (FDA) announced that it has accepted the supplemental New Drug Application (sNDA) for roflumilast foam 0.3% in adults and adolescents with scalp and body psoriasis ...
In this edition of The People's Pharmacy, Joe and Teresa Graedon also hear from a reader wondering about COVID-19-induced insulin resistance.
Equivalent potency to risankizumab with similar binding affinity and epitope demonstrated in several preclinical assays ...
To help soothe itchy skin, Dr. Massick and the American Academy of Dermatology recommend following these tips: Apply a cool, damp washcloth to itchy skin for about 5-10 minutes, or until the itch goes ...
The FDA has already approved Zoryve cream (0.3% and 0.15%) for plaque psoriasis and atopic dermatitis in adults and children ...
Does your hair's length affect how you take care of, maintain, and stop scalp psoriasis from returning? Let's talk about it.
Tremfya is a prescription drug used for psoriasis and psoriatic arthritis. Find out about possible interactions with alcohol, ...
A new study utilised data from the UK Biobank to shed light on a potential causal link between psoriasis and lung and breast ...
UCB (UCBJY) (UCBJF) said it has received FDA approval for its drug Bimzelx for the treatment of active psoriatic arthritis, ...
The US Food and Drug Administration has approved bimekizumab -bkzx (Bimzelx; UCB) for adult patients with active psoriatic ...
Spherix Global Insights compiled data from their RealTime Dynamix™ services in Crohn’s Disease, Rheumatoid Arthritis, and Psoriasis, fielded in late April 2024 (n=104 gastroenterologists, 103 ...
Less than a year after snagging its first FDA approval in psoriasis, UCB’s blockbuster hopeful Bimzelx has picked up three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback